Comparison of persistence rates between allopurinol and febuxostat as first-line urate-lowering therapy in patients with gout: an 8-year retrospective cohort study

被引：0
|
作者：
Aran Kim
Yunkyung Kim
Geun-Tae Kim
Eunyoung Ahn
Min Wook So
Seung-Geun Lee
机构：
[1] Pusan National University Hospital,Division of Rheumatology, Department of Internal Medicine
[2] Pusan National University School of Medicine,Biomedical Research Institute
[3] Pusan National University Hospital,Division of Rheumatology, Department of Internal Medicine
[4] Kosin University College of Medicine,Division of Rheumatology, Department of Internal Medicine
[5] Pusan National University Yangsan Hospital,undefined
来源：
Clinical Rheumatology | 2020年 / 39卷
关键词：
Allopurinol; Febuxostat; Gout; Medication adherence; Patient compliance; Uric acid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3769 / 3776
页数：7
相关论文
共 50 条
  • [21] Effect of Urate-lowering Therapy on the Risk of Cardiovascular Disease and All-cause Mortality in Patients with Gout: A Case-matched Cohort Study
    Chen, Jiunn-Horng
    Lan, Joung-Liang
    Cheng, Chi-Fung
    Liang, Wen-Miin
    Lin, Hsiao-Yi
    Tsay, Gregory J.
    Yeh, Wen-Ting
    Pan, Wen-Harn
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (09) : 1694 - 1701
  • [22] Effect of Urate-Lowering Therapy on All-Cause and Cardiovascular Mortality in Hyperuricemic Patients without Gout: A Case-Matched Cohort Study
    Chen, Jiunn-Horng
    Lan, Joung-Liang
    Cheng, Chi-Fung
    Liang, Wen-Miin
    Lin, Hsiao-Yi
    Tsay, Gregory J.
    Yeh, Wen-Ting
    Pan, Wen-Harn
    PLOS ONE, 2015, 10 (12):
  • [23] Cardiovascular events in patients with gout initiating urate-lowering therapy with or without colchicine for flare prophylaxis: a retrospective new-user cohort study using linked primary care, hospitalisation, and mortality data
    Cipolletta, Edoardo
    Nakafero, Georgina
    Mccormick, Natalie
    Yokose, Chio
    Avery, Anthony J.
    Mamas, Mamas A.
    Choi, Hyon K.
    Tata, Laila J.
    Abhishek, Abhishek
    LANCET RHEUMATOLOGY, 2025, 7 (03): : e197 - e207
  • [24] ANALYSIS OF APPROPRIATE DURATION OF COLCHICINE PROPHYLAXIS TO MAXIMIZE THE PERSISTENCE OF XANTHINE OXIDASE INHIBITORS AS THE FIRST-LINE URATE LOWERING THERAPY IN PATIENTS WITH GOUT USING THE KOREAN HEALTH INSURANCE REVIEW AND ASSESSMENT SERVICE DATABASE: DOES 6 MONTHS' DURATION MATTER?
    Kim, A.
    Lee, S. G.
    Song, B. W.
    Moon, D. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 529 - 529
  • [25] 8-year long term survival status in a phase III randomized study in EGFR mutated advanced lung cancer patients in the first-line
    Singh, A. C.
    Noronha, V.
    Patil, V. M.
    Menon, N. S.
    Prabhash, K.
    ANNALS OF ONCOLOGY, 2022, 33 : S1582 - S1582
  • [26] Comparison of first-line tuberculosis treatment outcomes between previously treated and new patients: a retrospective study in Machakos subcounty, Kenya
    Ndambuki, Johannes
    Nzomo, Joseph
    Muregi, Lucy
    Mutuku, Chris
    Makokha, Francis
    Nthusi, Jonathan
    Ambale, Clarice
    Lynen, Lutgarde
    Decroo, Tom
    INTERNATIONAL HEALTH, 2021, 13 (03): : 272 - 280
  • [27] Transarterial chemoembolization as first-line therapy for hepatocellular carcinomas infeasible for ultrasound-guided radiofrequency ablation: a retrospective cohort study of 116 patients
    Song, Yun Gyu
    Shin, Sung Wook
    Cho, Sung Ki
    Choi, Dongil
    Rhim, Hyunchul
    Lee, Min Woo
    Kim, Young-Sun
    Park, Kwang Bo
    Park, Hong Suk
    Choo, Sung Wook
    Do, Young Soo
    Choo, In-wook
    Hyun, Dongho
    ACTA RADIOLOGICA, 2015, 56 (01) : 70 - 77
  • [28] The 'real-life' impact of adding bevacizumab to first-line therapy in metastatic colorectal cancer patients: A large Israeli retrospective cohort study
    Hammerman, Ariel
    Greenberg-Dotan, Sari
    Battat, Erez
    Feldhamer, Ilan
    Bitterman, Haim
    Brenner, Baruch
    ACTA ONCOLOGICA, 2015, 54 (02) : 164 - 170
  • [29] Modeling Outcomes of First-Line Antiretroviral Therapy and Rate of CD4 Counts Change among a Cohort of HIV/AIDS Patients in Ethiopia: A Retrospective Cohort Study
    Awoke, Tadesse
    Worku, Alemayehu
    Kebede, Yigzaw
    Kasim, Adetayo
    Birlie, Belay
    Braekers, Roel
    Zuma, Khangelani
    Shkedy, Ziv
    PLOS ONE, 2016, 11 (12):
  • [30] Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study
    Mattia CF Prosperi
    Massimiliano Fabbiani
    Iuri Fanti
    Mauro Zaccarelli
    Manuela Colafigli
    Annalisa Mondi
    Alessandro D’Avino
    Alberto Borghetti
    Roberto Cauda
    Simona Di Giambenedetto
    BMC Infectious Diseases, 12
12345